Jennifer Ruddock | Head of Corporate Affairs |
Howard Robin | President and CEO |
Gil Labrucherie | COO and CFO |
Dr. Jonathan Zalevsky | Chief of Research and Development |
Dr. Brian Kotzin | Interim CMO and Head of Development |
Peter Lawson | Barclays |
Jay Olson | Oppenheimer |
Jessica Fye | JPMorgan |
Alex Bouilloux | Mizuho |
Ben Burnett | Stifel |
Daina Graybosch | SVB Leerink |
Arlinda Lee | Canaccord |
Good day, and thank you for standing by. Welcome to the Nektar Therapeutics First Quarter 2021 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference may be recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Ms. Jennifer Ruddock, Head of Corporate Affairs.